Patient involvement in outcome measures for psoriatic arthritis

William Tillett, Ade Adebajo, Mel Brooke, Willemina Campbell, Laura C Coates, Oliver Fitzgerald, Laure Gossec, Philip Helliwell, Sarah Hewlett, Jana James, Patricia Minnock, Aisling Reast, Dennis O'Sullivan, Maarten de Wit, Neil McHugh

Research output: Contribution to journalArticlepeer-review

33 Citations (SciVal)
272 Downloads (Pure)


Psoriatic arthritis (PsA) is a heterogeneous inflammatory arthritis with a varied clinical phenotype. There has been considerable international collaboration over recent years to develop and prioritise appropriate disease domains and outcome measures to capture all aspects of this complex disease. It has been recognised that patient-reported measures and physician assessments are complementary and, when used together, allow an improved reflection of disease burden. Taking this concept one step further, the experience in rheumatoid arthritis has demonstrated benefits of incorporating the patient perspective in the development of outcome measures. We report a systematic review demonstrating (1) that there has been little incorporation of the patient perspective in the development of outcome measures and domains in PsA, (2) the proceedings from the preliminary patient involvement in outcome measures for PsA (PIOMPSA) meetings, and (3) a proposed roadmap for improving patient involvement.
Original languageEnglish
Pages (from-to)1-10
Number of pages10
JournalCurrent Rheumatology Reports
Issue number5
Publication statusPublished - May 2014


Dive into the research topics of 'Patient involvement in outcome measures for psoriatic arthritis'. Together they form a unique fingerprint.

Cite this